• What is a Clinical Trial?
• Phases of Research
• How to Get Involved
• Currently Enrolling Studies
• Phase I: CPU
• Phase II-IV: Main Research
• Phase II-IV: West Side
• Privacy Statement
• FAQ's
• Research Participation Survey

Phase I: CPU

ID #: 615123 : Renal: To evaluate the safety and effects of study drug in subjects with Type 2 diabetes

	Study Medication:		Injectable
	Inclusion Criteria:		Mild/Moderate renal impairment;  Male or Females over the age of 18
	Study Length:		31 weeks/1overnight/20 visits
	Compensation:		$1500.00

ID #: 615124 : Renal: To assess the effect of mild, moderate and severe Renal Impairment on study drug

	Study Medication:		Oral Pill
	Inclusion Criteria:		Males and Females;  Ages 18-79 years old with mild, moderate, severe Renal Impairment
	Study Length:		25 days/7 overnights
	Compensation:		$1070.00

ID #: 615132 : HEALTY Oral Medication for obesity

	Study Medication:		Oral Pill
	Inclusion Criteria:		Males and Females;  M//F 18-65 Non Smokers
	Study Length:		8 weeks/3 overnight stays
	Compensation:		$1275.00

ID #: 615134 : Diabetes Type 2: Assess IV single-dose tolerance of study drug in overweight Type 2 Diabetics

	Study Medication:		Injectable
	Inclusion Criteria:		Type II Diabetes;  Diet Controlled or on oral medication; males and females 18 to 65 years old and overweight
	Study Length:		9 weeks/4 overnights/3 visits
	Compensation:		$1100.00

ID #: 615135 : Diabetes Type 2: To evaluate the effects of study drug on Hepatic Insulin Sensitivity, Gluconeogenesis, Glucose Absorption and Lipid Synthesis in Subjects with Type 2 Diabetes

	Study Medication:		Oral Pill
	Inclusion Criteria:		Type II Diabetes;  Males or females 30 to 70 years old; Must be diet controlled or on oral medication
	Study Length:		85 days/2 overnights/4 visits
	Compensation:		$1500.00

ID #: 615140 : Diabetes Type 2: Dose safety and tolerability in non insulin dependent patients

	Study Medication:		Oral Pill
	Inclusion Criteria:		Males Only;  Ages 35-65; non smoker; no Type 1 diabetics
	Study Length:		70 days/4 overnights (2 nights intervals) & 6 visits
	Compensation:		$1750.00

ID #: 615141 : Cholesterol: To assess the effects of study drug in male subjects with low HDL-c (good cholesterol) levels

	Study Medication:		Oral Pill
	Inclusion Criteria:		Males Only;  Non-Diabetic; 18 to 70 years old; no smokers
	Study Length:		up to 116 days/ 2 overnights/4 visits
	Compensation:		$800.00

ID #: 615125 : Renal: To evaluate the safety and efficacy of study drug in patients with Renal Impairment to volunteers with normal renal function

	Study Medication:		Oral Pill
	Inclusion Criteria:		Severe renal impairment;  Male or Female 18 years of age or older
	Study Length:		28 days/5 overnights/1 visit
	Compensation:		$1500.00